DOJ lawsuit reins in inappropriate ICD use

Friday, July 6, 2018

A reanalysis of the ATLAS ACS 2-TIMI 51 trial shows rivaroxaban in a different light; cerebral protection may be appropriate in all TAVR procedures, regardless of anatomy; the Feds' big stick vs. carrot approach worked in cutting inappropriate ICD use: and canagliflozin's perported amputation risk didn't make a showing in a real-word study.

How to Listen

Podcast Participants

^{Jim Dwyer, MD}

Jim Dwyer MD, FACC, FSCAI, is a cardiologist and avid horseman in Prescott, Ariz. Trained at Saint Louis University, he spent more than 30 years in interventional cardiology. He recently hung up his lead apron and has joined a private cardiology practice. Dr. Dwyer has been producing health segments for radio broadcast for 20 years. He has no disclosures.